Temporal Trends in the Use of Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrest
Autor: | Gary K. Grunwald, Michael R. Mooney, Timothy D. Henry, Bryan McNally, Kimberly Vellano, Steven M. Bradley, Wenhui Liu, Saket Girotra, Mehul Adhaduk, M. Nicholas Burke, Emmanouil S. Brilakis, Michael W. Donnino |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Cardiology 030204 cardiovascular system & hematology Targeted temperature management Ventricular tachycardia 03 medical and health sciences 0302 clinical medicine Patient Admission Hypothermia Induced Internal medicine medicine Odds Ratio Humans 030212 general & internal medicine Hospital Mortality Registries Asystole Practice Patterns Physicians' Pulse Original Investigation Aged Randomized Controlled Trials as Topic Retrospective Studies business.industry Research Retrospective cohort study General Medicine Odds ratio Hypothermia Middle Aged medicine.disease United States Heart Arrest Online Only Logistic Models Pulseless electrical activity Ventricular fibrillation Practice Guidelines as Topic Ventricular Fibrillation Tachycardia Ventricular Female Guideline Adherence medicine.symptom business Out-of-Hospital Cardiac Arrest |
Zdroj: | JAMA Network Open |
ISSN: | 2574-3805 |
Popis: | Importance Despite evidence that therapeutic hypothermia improves patient outcomes for out-of-hospital cardiac arrest, use of this therapy remains low. Objective To determine whether the use of therapeutic hypothermia and patient outcomes have changed after publication of the Targeted Temperature Management trial on December 5, 2013, which supported more lenient temperature management for out-of-hospital cardiac arrest. Design, Setting, and Participants A retrospective cohort was conducted between January 1, 2013, and December 31, 2016, of 45 935 US patients in the Cardiac Arrest Registry to Enhance Survival who experienced out-of-hospital cardiac arrest and survived to hospital admission. Exposures Calendar time by quarter year. Main Outcomes and Measures Use of therapeutic hypothermia and patient survival to hospital discharge. Results Among 45 935 patients (17 515 women and 28 420 men; mean [SD] age, 59.3 [18.3] years) who experienced out-of-hospital cardiac arrest and survived to admission at 649 US hospitals, overall use of therapeutic hypothermia during the study period was 46.4%. In unadjusted analyses, the use of therapeutic hypothermia dropped from 52.5% in the last quarter of 2013 to 46.0% in the first quarter of 2014 after the December 2013 publication of the Targeted Temperature Management trial. Use of therapeutic hypothermia remained at or below 46.5% through 2016. In segmented hierarchical logistic regression analysis, the risk-adjusted odds of use of therapeutic hypothermia was 18% lower in the first quarter of 2014 compared with the last quarter of 2013 (odds ratio, 0.82; 95% CI, 0.71-0.94; P = .006). Similar point-estimate changes over time were observed in analyses stratified by presenting rhythm of ventricular tachycardia or ventricular fibrillation (odds ratio, 0.89; 95% CI, 0.71-1.13, P = .35) and pulseless electrical activity or asystole (odds ratio, 0.75; 95% CI, 0.63-0.89; P = .001). Overall risk-adjusted patient survival was 36.9% in 2013, 37.5% in 2014, 34.8% in 2015, and 34.3% in 2016 (P This cohort study examines whether the use of therapeutic hypothermia and patient survival have changed after publication of the Targeted Temperature Management trial, which supported more lenient temperature management for out-of-hospital cardiac arrest. Key Points Question Did the use of therapeutic hypothermia for out-of-hospital cardiac arrest change after publication of a trial that supported more lenient temperature goals? Findings In a cohort study of 45 935 US patients who experienced out-of-hospital cardiac arrest and survived to hospital admission, the risk-adjusted odds of the use of therapeutic hypothermia decreased 18% in the first quarter of 2014 after publication of the Targeted Temperature Management trial, compared with the last quarter of 2013. Risk-adjusted patient survival also decreased during the study period, but was not mediated by trends in hypothermia use. Meaning In a US registry of patients who experienced out-of-hospital cardiac arrest, the use of guideline-recommended active cooling decreased after publication of the Targeted Temperature Management trial. |
Databáze: | OpenAIRE |
Externí odkaz: |